Scott Barros
Impact in
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Lipid Membrane Structure and Behavior
- CRISPR and Genetic Engineering
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 7
- Cancer-related gene regulation 3
- DNA and Nucleic Acid Chemistry 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Akin Akinc (6 shared papers)Muthiah Manoharan (3 shared papers)Xinyao Du (1 shared paper)Sean C. Semple (1 shared paper)Muthusamy Jayaraman (2 shared papers)Thomas D. Madden (1 shared paper)Ying K. Tam (1 shared paper)Martin A. Maier (2 shared papers)
- Journals
- Blood (4 papers)Nucleic Acid Therapeutics (3 papers)Nature Communications (1 paper)Gene (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Scott Barros
20 papers receiving 2.4k citations
Scott Barros's Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.9k
- Biomaterials 361
- Cancer Research 225
- Hepatology 115
- Immunology 287
Countries citing papers authored by Scott Barros
This map shows the geographic impact of Scott Barros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Barros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Barros more than expected).
Fields of papers citing papers by Scott Barros
This network shows the impact of papers produced by Scott Barros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Barros. The network helps show where Scott Barros may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Barros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs Hit paper breakdown → | 2019 | 1233 |
| 2 | Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity Hit paper breakdown → | 2014 | 508 |
| 3 | 2014 | 183 | |
| 4 | 2001 | 153 | |
| 5 | 2012 | 103 | |
| 6 | 2008 | 40 | |
| 7 | 2012 | 38 | |
| 8 | 2016 | 35 | |
| 9 | 2016 | 33 | |
| 10 | 2006 | 23 | |
| 11 | 2016 | 22 | |
| 12 | 2006 | 20 | |
| 13 | 2003 | 17 | |
| 14 | 2014 | 14 | |
| 15 | 2008 | 9 | |
| 16 | 2015 | 8 | |
| 17 | 2012 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2013 | 1 | |
| 20 | Abstract 15574: A Subcutaneous Platform for RNAi Therapeutics Targeting ANGPTL3 | 2013 | 1 |
About Scott Barros
Scott Barros is a scholar working on Molecular Biology, Oncology, Cancer Research, Hematology and Computational Theory and Mathematics, having authored 20 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (7 papers), Drug Transport and Resistance Mechanisms (4 papers), MicroRNA in disease regulation (4 papers), Hemophilia Treatment and Research (3 papers), Cancer-related gene regulation (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Biomaterials (361 citations), Cancer Research (225 citations), Hepatology (115 citations) and Immunology (287 citations). Scott Barros has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Akin Akinc, Muthiah Manoharan, Xinyao Du, Sean C. Semple, Muthusamy Jayaraman, Thomas D. Madden, Ying K. Tam, Martin A. Maier, Steven M. Ansell and Barbara L. Mui. Their work appears in journals such as Blood, Nucleic Acid Therapeutics, Nature Communications, Gene and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.